A recent study posted in the Cell Reports Journal reported the identification of a panel of vaccinee-derived antibodies with broad-spectrum neutralization activity.
Study: Potent, omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before omicron emergence. Image Credit: FamVeld/Shutterstock.com
Background
As the coronavirus disease 2019 (COVID-19) continues to spread, therapeutic options are running out due to the emergence of multi-resistant variants and strains of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
This study…
Continue Reading
News Source: www.news-medical.net